Day: October 15, 2020

Uncovering solutions for affordable drug pricing

The House Committee on Oversight and Reform held a series of hearings to review findings from an in-depth investigation into drug pricing actions that was conducted last year with CEOs representing some of the largest and most profitable pharmaceutical manufacturers. As stated in the summary report of the investigation by Chairwoman Carolyn Maloney, “the drug …

Uncovering solutions for affordable drug pricing Read More »